Rigel Pharmaceuticals (RIGL) Surpasses Q4 Earnings and Revenue Estimates

Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of$0.55 per share. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 45.45%. A quarter ago, it was expected that this drug developer would post earnings of $0.01 per share when it actually produced earnings of$0.70, delivering a surprise of 6,900%.Over the last four quarter ...